PARTNERING
Unlock the Full Potential of Your Cell Therapy
×
Technology
Cell Shuttle™
Cartridge
Cell Q™
Software
IDMO
IDMO Capabilities
IDMO Advantage
IDMO Smart Factories
Services
IDMO Services
The IDMO Journey
Begin the Journey
Globalization
Service Models
Existing Partners
Company
Mission
Board of Directors
Board of Advisors
Investors
Resources
Contact
Careers
Interdisciplinary Team
Culture & Values
Perks
Opportunities
News
Partner with us
Cellares
Technology
Cell Shuttle™
Cartridge
Cell Q™
Software
IDMO
IDMO Capabilities
IDMO Advantage
IDMO Smart Factories
Services
IDMO Services
The IDMO Journey
Begin the Journey
Globalization
Service Models
Existing Partners
Company
Mission
Board of Directors
Board of Advisors
Investors
Resources
Contact
Careers
Interdisciplinary Team
Culture & Values
Perks
Opportunities
News
Partner with us
November 14, 2022
Business Insider
Inside The Modular Factory Set To Disrupt Cell Therapy | United States Of Automation
Related News
February 03, 2026
Cellares to Expand Automated Manufacturing to Gene-Edited Stem Cell Therapies
January 28, 2026
Cellares Raises $257 Million Series D Led by BlackRock and Eclipse to Industrialize Global Cell Therapy Manufacturing with Breakthrough Automation
January 12, 2026
IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares’ Automated Platform